INTRODUCTION
Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus that infects about [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] million people worldwide with endemic foci in Southern Japan, the Caribbean, Central and South Africa, and South America. Less than 5% of HTLV-1 infected individuals develop either adult T-cell leukemia (ATL) or a chronic inflammatory disease of the central nervous system termed HTLV-1 associated myelopathy / tropical spastic paraparesis (HAM/TSP). HTLV-1 also has been implicated in a broader spectrum of diseases including uveitis, infective dermatitis, polymyositis, arthropathy, and Sjögren's syndrome [1] [2] [3] . HTLV-1 associated diseases may be accompanied by pulmonary disorders and immunosuppression and it is noteworthy that patients with acute ATL generally succumb to opportunistic infections 4 . The majority of HTLV-1 proviruses are found in CD4+and in CD8+ T-cells [5] [6] [7] and there is a clonal expansion of HTLV-1 infected CD4+ T-cells 8 .
HTLV-1 infection of primary T-cells in vitro results in the infrequent establishment of
chronically infected T-cell lines that continuously proliferate in the absence of antigenic stimulation, but most require IL-2 for growth [9] [10] [11] [12] . A small number of HTLV-1 infected T-cell lines also have been established that do not require IL-2, but these do not closely resemble patient-derived HTLV-1 infected T-cells 13 . The viral trans-regulatory protein, Tax, is the primary effector of T-cell transformation. In addition to its role in activating virus transcription, Tax alters the expression or function of signal transduction proteins, cell cycle regulators and transcription factors 14 . Targets of the Tax protein also include cytokine promoters [15] [16] [17] [18] [19] and dysregulation of cytokine expression in HTLV-1 infected individuals may play an important role in the course of disease.
3 only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal 
.hematologylibrary.org From
Although expression patterns of a number of cytokines have been studied in HTLV-1 infected cells, IL-13 has not been examined in this context. Because IL-13 is a key mediator of various immune functions [20] [21] [22] , including the inhibition of tumor immunosurveillance 23, 24 and the pathophysiology of asthma 25, 26 , we asked whether its expression is altered in HTLV-1 infected T-cells. IL-13 mRNA was expressed at high levels in ten independent, chronically infected T- were analyzed with a multiprobe RNase protection assay (RPA) using total cellular RNA from each cell culture (Fig. 1) . None of the cytokine mRNAs surveyed were expressed at detectable levels in the uninfected Jurkat and Kit 225 T-cell lines (Fig. 1, lanes 1 and 2) . Activated CD4+ and CD8+ T-cells (lanes 3 and 4) both expressed IL-13 and IFN-γ mRNAs; CD4+ T-cells expressed IL-2 mRNA and CD-8+ T-cells expressed IL-5 mRNA at low but detectable levels.
The cytokine mRNA expression patterns among the IL-2 independent, HTLV-1 transformed T-cells (MT-2, HuT-102, C8166, and C10-MJ) were highly variable and with several exceptions, barely detectable levels of cytokine mRNAs were expressed (Fig. 1, lanes 5-8) . The HuT-102 cell line (lane 6) expressed IL-15 mRNA at high levels as previously 
Secretion of IL-13 protein in HTLV-1 infected T-cells
We next determined IL-13 protein levels in supernatants from the T-cell lines by enzyme linked immunosorbent assay (ELISA) (Fig. 2A) . IL-13 protein was not detected in
supernatants from Jurkat cells but was produced at low levels from activated CD4+ T-cells.
Among the HTLV-1 positive cell lines, IL-13 was not detected in MT2 and HuT-102 cell cultures. Low levels of IL-13 were detected in C8166, C10/MJ cells, and A212 cultures. All of the other HTLV-1 infected cell lines produced IL-13 at levels ranging between 4 ng/ml and 21 ng/ml. These protein levels corresponded to IL-13 mRNA band intensities in Figure 1 . We also examined the levels of HTLV-1 Tax mRNA expressed in these cell lines by quantitative real-time PCR analysis (Fig. 2B) . Tax 
HTLV-1 Tax transactivates the IL-13 promoter
The ability of Tax to activate the IL-13 promoter was examined by cotransfecting Jurkat T-cells with luciferase reporter plasmids controlled by the IL-13 promoter in combination with a Tax expression plasmid (Fig.3) . IL-13 reporter plasmids containing promoter sequences 357 bp (pD3397) or 155 bp (pD3402) upstream of the RNA start site were activated approximately 18-fold by Tax (Fig. 3B) . The IL-13 promoter fragment in pD3403 contains only 67 bp upstream of the RNA start site and was not activated by ectopic expression of Tax (Fig. 3B) . 
IL-13 expression in CD4+ T-cells from HTLV-1 infected individuals
We next asked whether IL-13 expression is activated in T-cells from HTLV-1 infected individuals. To this end, PBMCs were collected from one normal donor, three asymptomatic HTLV-1 carriers and three HAM/TSP patients. PBMCs were cultured for 24 hours in medium containing concanamycin A (to inhibit CTL activity) and brefeldin A (to inhibit IL-13 secretion), but without IL-2 or mitogens. Cells were then fixed and stained for cell surface markers with fluorescent dye-conjugated anti-CD4 and anti-CD8 antibodies followed by intracellular staining for Tax and IL-13. Stained cells were analyzed by four-color flow cytometry; Tax and IL-13 expression were examined in cells gated for CD4. Tax protein was not detected in the CD4+ Tcells from the HTLV-negative, healthy donor (Fig 4) . In contrast, Tax protein was detected in CD4+ T-cells from both HAM/TSP patients and asymptomatic carriers. The relative number of Tax expressing CD4+ T-cells varied from 8.36% to 38.1% among the HAM/TSP patient samples and correlated with provirus load, which ranged from 2.8% to 41.4% (Table 1 ). Compared to the HAM/TSP samples, CD4+ T-cells from asymptomatic carriers had lower provirus loads (1.3% to 1.6%) and fewer Tax-expressing CD4+ T-cells (0.44% to 4.24%). IL-13 protein was expressed in HTLV-1 infected CD4+ T-cells from both HAM/TSP patients and asymptomatic HTLV-1 carriers (Fig. 4 and Table 1 ). IL-13 protein was expressed exclusively in cells that also expressed Tax; in fact, there was a direct correlation between the intensity of staining for Tax and expression of IL-13. This was most apparent in lymphocytes from the HAM/TSP patient designated TBI (Fig. 4) . The IL-13 signal was observed with two different anti-IL-13 mAbs and could be blocked by addition of exogenous IL-13; no IL-13 signal was detected with a matched 13 only.
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Kinetics of Tax and IL-13 expression in ex vivo cultures of CD4+ T-cells
It has been reported previously that fresh PBMCs from HTLV-1 infected patients express very low levels of virus, but for unknown reasons virus expression becomes detectable soon after the start of in vitro culture 19 . We exploited this phenomenon to examine the kinetics of Tax For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From
